Dr. Najla Itani, MD

Dr. Itani practices at Conway Medical Center in Conway, South Carolina, part of Conway Medical Center.

Dr. Itani's NPI, 1073868097, was assigned on July 16, 2012. Dr. Itani holds South Carolina license 82438.

Dr. Itani's primary practice is Conway Medical Center, at 300 Singleton Ridge Road, Conway, SC 29526 in Horry County. The practice phone is (843) 347-8037.

Dr. Itani's primary practice is Conway Medical Center in Conway, South Carolina, part of Conway Medical Center. The medical group on file is Conway Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Itani practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Itani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Itani is board certified in hematology by the American Board of Internal Medicine. Dr. Itani is licensed in South Carolina.

CMS data shows 399 Medicare services from Dr. Itani across 2 procedure codes in 2024, all of them office visits, for 176 Medicare patients. Medicare paid $23,538 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 176 Medicare patients who saw Dr. Itani in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Itani's median patient age at 73, with 63% women.

In 2024, Dr. Itani wrote 388 Medicare Part D claims for 94 patients. 82% of them were for generic drugs. CMS names the drug for 265 of them, across 11 drugs with 11 or more claims each, at $656,282 in total drug cost. In 2023, CMS named 213 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 53 out of 100 for Dr. Itani for performance year 2024, reported as part of a group. Dr. Itani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Itani as offering telehealth.

Dmand AI links 2 papers to Dr. Itani in 2019. 2019 was the busiest year, with 2. The most frequent topics are Breast Neoplasms. Dr. Itani's most frequent co-author is Sneha D. Phadke, DO.

CMS Open Payments shows 10 general payments to Dr. Itani from 7 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 94% of the total. Daiichi Sankyo Inc. paid the most, $119.